Vantage Clinical Trials LLC

1. Sanofi US Services Inc. $210,889 27 payments
2. Lexicon Pharmaceuticals, Inc. $113,193 19 payments
3. Otsuka Pharmaceutical Development & Commercialization, Inc. $47,393 3 payments
4. Roche TCRC, Inc. $35,483 7 payments
5. AbbVie, Inc. $34,274 10 payments
6. GRT US Holding, Inc. $28,990 8 payments
7. GW Research Limited $25,786 8 payments
8. LivaNova USA, Inc. $20,768 17 payments
9. Chiesi USA, Inc. $12,500 1 payment
10. Jazz Pharmaceuticals Inc. $2,783 2 payments

1. Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) $139,774 16 payments
2. Lx9211.1-204-Dpn $84,803 15 payments
3. A Multi-Center, Randomized, Controlled Trial to Evaluate the Effectiveness of A Digital Therapeutic (CT-152) As Adjunctive Therapy in Adult Subjects Diagnosed With Major Depressive Disorder $42,393 2 payments
4. A double-blind extension study to evaluate the long-term safety and tolerability of itepekimab in patients with chronic obstructive pulmonary disease (COPD) who participated in either EFC16750 or EFC16819 clinical studies $38,492 8 payments
5. The Effect of 24Week Treatment With Basmisanil on Cognitive Impairment Associated With Schizophrenia $35,483 7 payments
6. Kf7013-04 $28,990 8 payments
7. Lx9211 $28,389 4 payments
8. Gwap19030 $25,786 8 payments
9. Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine $21,774 9 payments
10. ACT - POC clinical study - IL13 x TSLP Nanobody VHH - lunsekimig $19,115 2 payments

1. Patient care $71,509 9 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.